naltrexone has been researched along with Binge Alcohol Consumption in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A; Arenander, J; Batki, S; Coffin, P; Ikeda, J; Jain, J; Matheson, T; McLaughlin, M; Santos, GM; Vittinghoff, E; Walker, J | 1 |
| Garbutt, JC; Kampov-Polevoy, A; Navarro, M; Pedersen, C; Thiele, TE; Walter, TJ | 1 |
| Font, L; Morales, I; Pastor, R; Rodríguez-Borillo, O | 1 |
| Blasio, A; Cottone, P; DiLeo, A; Sabino, V; Valenza, M | 1 |
| Fletcher, PJ; Lê, AD; Li, Z; Tabbara, RI | 1 |
| Barkley-Levenson, A; Crabbe, JC; Hack, WR; Huang, LC; Metten, P; Ozburn, AR; Schlumbohm, JP; Spence, SE | 1 |
| Buisman-Pijlman, FT; Hutchinson, MR; Jacobsen, JHW; Mustafa, S; Rice, KC | 1 |
| Diouf, M; González-Marín, MC; Jeanblanc, J; Lebourgeois, S; Naassila, M | 1 |
| Anderson, RI; Becker, HC; Bloodgood, DW; Boyt, KM; Griffin, WC; Haun, HL; Kash, TL; Lopez, MF; Pati, D | 1 |
| Garbutt, JC; Kampov-Polevoy, AB; Luhn, KL; Navarro, M; Thiele, TE | 1 |
| Haddouk, H; Hwa, LS; Kalinichev, M; Miczek, KA; Poli, S | 1 |
| Corbin, WR; Fucito, LM; Leeman, RF; O'Malley, SS; Toll, BA; Zalewski, S | 1 |
| Borro, P; Leone, S; Testino, G | 1 |
| Carvajal, F; Cubero, I; Lerma-Cabrera, JM; Navarro, M; Picker, MJ; Thiele, TE | 1 |
| Batki, SL; Coffin, P; DeMartini, A; Euren, J; Hahn, JA; Huffaker, S; Matheson, T; Rowe, C; Santos, D; Santos, GM; Vittinghoff, E; Vlahov, D | 1 |
| Cottone, P; Kwak, J; Rice, KC; Sabino, V | 1 |
1 review(s) available for naltrexone and Binge Alcohol Consumption
| Article | Year |
|---|---|
Treatment of alcohol dependence: recent progress and reduction of consumption.
Topics: Acamprosate; Age of Onset; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Binge Drinking; Contraindications; Craving; Disulfiram; Drugs, Investigational; Europe; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Naltrexone; Neurotransmitter Agents; Randomized Controlled Trials as Topic; Sodium Oxybate; Taurine | 2014 |
4 trial(s) available for naltrexone and Binge Alcohol Consumption
| Article | Year |
|---|---|
Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial.
Topics: Alcohol Drinking; Alcoholism; Binge Drinking; Ethanol; Humans; Male; Naltrexone; Sexual and Gender Minorities | 2022 |
A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.
Topics: Adult; Binge Drinking; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Naltrexone; Young Adult | 2020 |
In with the old and out with the new? A comparison of the old and new binge drinking standards.
Topics: Adolescent; Adult; Alcohol Deterrents; Alcoholic Intoxication; Alcoholism; Binge Drinking; Counseling; Double-Blind Method; Drinking Behavior; Ethanol; Female; Humans; Male; Naltrexone; Regression Analysis; Risk Factors; Self Report; Sex Factors; Time Factors; Treatment Outcome; Young Adult | 2014 |
Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Binge Drinking; Condoms; Counseling; Double-Blind Method; Homosexuality, Male; Humans; Male; Methamphetamine; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Risk Reduction Behavior; Risk-Taking; Sexual Behavior; Substance-Related Disorders; Unsafe Sex; Young Adult | 2016 |
11 other study(ies) available for naltrexone and Binge Alcohol Consumption
| Article | Year |
|---|---|
Effects of naltrexone on alcohol, sucrose, and saccharin binge-like drinking in C57BL/6J mice: a study with a multiple bottle choice procedure.
Topics: Animals; Behavior, Addictive; Binge Drinking; Binge-Eating Disorder; Ethanol; Male; Mice; Mice, Inbred C57BL; Models, Animal; Naltrexone; Narcotic Antagonists; Saccharin; Self Administration; Sucrose | 2020 |
Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.
Topics: Animals; Binge Drinking; Central Nervous System Depressants; Dose-Response Relationship, Drug; Ethanol; Guanidines; Male; Morphine; Naltrexone; Narcotic Antagonists; Rats; Receptors, sigma; Self Administration | 2020 |
The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking.
Topics: Animals; Benzazepines; Binge Drinking; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Mice, Inbred C57BL; Models, Animal; Naltrexone; Narcotic Antagonists; Receptor, Serotonin, 5-HT2C; Saccharin; Self Administration; Serotonin 5-HT2 Receptor Agonists | 2021 |
High Drinking in the Dark (HDID) mice are sensitive to the effects of some clinically relevant drugs to reduce binge-like drinking.
Topics: Acamprosate; Animals; Baclofen; Binge Drinking; Darkness; Disease Models, Animal; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Naltrexone; Taurine | 2017 |
Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Animals, Newborn; Binge Drinking; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Ethanol; Female; gamma-Aminobutyric Acid; Mice; Mice, Inbred BALB C; Naltrexone; Pregnancy; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2018 |
Evaluation of alcohol use disorders pharmacotherapies in a new preclinical model of binge drinking.
Topics: Acamprosate; Animals; Baclofen; Binge Drinking; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Extinction, Psychological; Hydroxybutyrates; Male; Motivation; Naltrexone; Rats; Self Administration | 2018 |
Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Behavior, Animal; Binge Drinking; Central Amygdaloid Nucleus; Disease Models, Animal; Dynorphins; Genetic Techniques; Male; Mice; Mice, Inbred C57BL; Naltrexone; Receptors, Opioid, kappa | 2019 |
Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
Topics: Alcohol Deterrents; Animals; Binge Drinking; Bupropion; Central Nervous System Depressants; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanol; Male; Mice; Mice, Inbred C57BL; Naltrexone; Self Administration | 2019 |
Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice.
Topics: Acetamides; Alcohol Deterrents; Alcohol Drinking; Allosteric Regulation; Animals; Bacterial Proteins; Binge Drinking; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking; GABA-B Receptor Agonists; Male; Mice; Naltrexone; Transcription Factors; Triazines | 2014 |
Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.
Topics: alpha-MSH; Animals; Binge Drinking; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethanol; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Peptides, Cyclic; Receptors, Melanocortin | 2015 |
Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking.
Topics: Alcohol Drinking; Animals; Benzazepines; Binge Drinking; Choice Behavior; Disease Models, Animal; Dopamine Antagonists; Ethanol; Male; Naltrexone; Narcotic Antagonists; Pyrimidines; Rats; Receptors, Corticotropin-Releasing Hormone; Self Administration | 2013 |